title: Serum levels of CC chemokine receptor 4 and CXC chemokine receptor 3 ligands in CD8(+) Sézary syndrome.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Uchi
authors.forename: Sayaka
authors.initials: S
authors.lastname: Hayashida
authors.forename: Masakazu
authors.initials: M
authors.lastname: Takahara
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Moroi
authors.forename: Masutaka
authors.initials: M
authors.lastname: Furue
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D016827:CD8 Antigens / Q000378:metabolism; D018925:Chemokines / Q000097:blood*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D054398:Receptors, CCR4 / Q000097:blood; D054367:Receptors, CXCR3 / Q000097:blood; D012751:Sezary Syndrome / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D012878:Skin Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism
chemical_list: D000964:Antimetabolites, Antineoplastic; D016827:CD8 Antigens; C515187:CXCR3 protein, human; D018925:Chemokines; D054398:Receptors, CCR4; D054367:Receptors, CXCR3; D008727:Methotrexate